Company Performance: PRL.DU's financial health, including revenue, profit, and debt levels, directly impacts its stock price.

Market Sentiment: Overall investor confidence and optimism or pessimism towards the stock market influence PRL.DU's valuation.

Industry Trends: The performance and outlook of the pharmaceutical industry affect PRL.DU, as investors view it within this sector.

Economic Conditions: Macroeconomic factors like interest rates, inflation, and GDP growth play a role in investor decisions concerning PRL.DU.

Regulatory Changes: Government regulations affecting drug development, pricing, or approvals can impact PRL.DU's prospects.

Competition: Actions by rival pharmaceutical companies, including new drug releases, can affect PRL.DU's market share and stock price.

Drug Pipeline: The success or failure of PRL.DU's drug development pipeline significantly influences investor expectations and valuation.

News and Events: Company-specific news, such as earnings reports, clinical trial results, or partnerships, can trigger stock price fluctuations.

Global Events: International events, like political instability or pandemics, may affect global markets and indirectly impact PRL.DU.